Movatterモバイル変換


[0]ホーム

URL:


BE652938A - - Google Patents

Info

Publication number
BE652938A
BE652938ABE652938DABE652938ABE 652938 ABE652938 ABE 652938ABE 652938D ABE652938D ABE 652938DABE 652938 ABE652938 ABE 652938A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of BE652938ApublicationCriticalpatent/BE652938A/xx

Links

Classifications

Landscapes

BE652938D1963-09-131964-09-10BE652938A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
DET00247071963-09-13
DET00247061963-09-13

Publications (1)

Publication NumberPublication Date
BE652938Atrue BE652938A (en)1965-03-10

Family

ID=25999762

Family Applications (1)

Application NumberTitlePriority DateFiling Date
BE652938DBE652938A (en)1963-09-131964-09-10

Country Status (7)

CountryLink
BE (1)BE652938A (en)
CH (1)CH430722A (en)
DE (1)DE1470350B1 (en)
DK (2)DK107553C (en)
FR (1)FR4016M (en)
GB (1)GB1068744A (en)
SE (1)SE323683B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE2918832A1 (en)*1979-05-101980-11-20Basf Ag 5,6-DIHYDRO-11-ALKYLENE-MORPHANETRIDINE-6-ONE
GB8914061D0 (en)*1989-06-191989-08-09Wellcome FoundAgents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914040D0 (en)*1989-06-191989-08-09Wellcome FoundAgents for potentiating the effects of antitumour agents and combating multiple drug resistance
DK0409406T3 (en)*1989-06-191994-02-07Wellcome Found Aryl-substituted amine derivatives useful in cancer therapy
GB8914060D0 (en)*1989-06-191989-08-09Wellcome FoundAgents for potentiating the effects of antitumour agents and combating multiple drug resistance
US5208238A (en)*1989-06-191993-05-04Burroughs Wellcome CompanyAgents for potentiating the effects of antitumor agents and combating multiple drug resistance

Also Published As

Publication numberPublication date
FR4016M (en)1966-03-21
DE1470350B1 (en)1970-04-02
DK107553C (en)1967-06-12
CH430722A (en)1967-02-28
DK107483C (en)1967-06-05
GB1068744A (en)1967-05-10
SE323683B (en)1970-05-11

Similar Documents

PublicationPublication DateTitle
AR142945A1 (en)
FR4016M (en)
BE627012A (en)
BE533484A (en)
BE31062A (en)
BE462764A (en)
BE465565A (en)
BE507458A (en)
BE547422A (en)
BE582314A (en)
BE603935A (en)
BE608372A (en)
BE612803A (en)
BE614220A (en)
BE616247A (en)
BE616830A (en)
BE616967A (en)
BE619061A (en)
BE620325A (en)
BE621232A (en)
BE621517A (en)
BE622160A (en)
BE623117A (en)
BE623220A (en)
BE623315A (en)

[8]ページ先頭

©2009-2025 Movatter.jp